Effectiveness of expanding annual mass azithromycin distribution treatment coverage for trachoma in Niger: A cluster randomized trial

BACKGROUND/AIMS: The World Health Organization recommends 3–5 years of annual mass azithromycin distribution with at least 80% treatment coverage to districts with active trachoma prevalence over 10% among children. Here, we assess the efficacy of expanding the coverage target to at least 90% for tr...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Br J Ophthalmol
Egile Nagusiak: Amza, Abdou, Kadri, Boubacar, Nassirou, Beido, Cotter, Sun Y., Stoller, Nicole E., West, Sheila K., Bailey, Robin L., Porco, Travis C., Gaynor, Bruce D., Keenan, Jeremy D., Lietman, Thomas M., Oldenburg, Catherine E.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2017
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5845832/
https://ncbi.nlm.nih.gov/pubmed/28893761
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjophthalmol-2017-310916
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak